نتایج جستجو برای: uremic syndrome

تعداد نتایج: 624615  

Journal: :American journal of kidney diseases : the official journal of the National Kidney Foundation 2002
Roland B Walter Markus Joerger Bernhard C Pestalozzi

BACKGROUND Gemcitabine has mild renal toxicity, but cases of gemcitabine-associated hemolytic-uremic syndrome (HUS) have been reported. METHODS A case is presented of a 45-year-old woman on prolonged gemcitabine treatment for ovarian cancer who developed HUS and recovered after drug discontinuation. A mini-review of the literature based on a MEDLINE search follows. RESULTS Including our own...

Journal: :Nephron 1985
F E von Eyben W Szpirt

F.E. von Eyben, PhD, MD, Klovervanget 22 a 11, DK-5000 Odense (Denmark) Dear Sir, Hemolytic-uremic syndrome comprises a triad of findings: acute microangiopathic hemolytic anemia, thrombocytopenia, and acute renal insufficiency [1]. In most cases of hemolytic-uremic syndrome in the adult the etiology is unknown, but a few cases have been reported as complications of typhoid fever [2], E. coli a...

Journal: :Current Opinion in Nephrology and Hypertension 2012

Journal: :Indian Journal of Critical Care Medicine 2017

2012
Seyed-Ali Sadjadi Pavan Annamaraju

BACKGROUND Gemcitabine is frequently used for the treatment of many cancers. Not infrequently it leads to development of hemolytic uremic syndrome, presenting with hemolytic anemia, acute kidney injury and occasionally peripheral edema, livedo reticularis and digital necrosis. CASE REPORT A 78 year old man with non-small cell lung cancer developed uremic syndrome following treatment with mult...

2014
David Kavanagh Shreya Raman Neil S. Sheerin

Hemolytic uremic syndrome (HUS) is a disease characterized by hemolysis, thrombocytopenia, and acute kidney injury, although other organs may be involved. Most cases are due to infection with Shiga toxin-producing Escherichia coli (STEC). Early identification and initiation of best supportive care, with microbiological input to identify the pathogen, result in a favorable outcome in most patien...

2017
Vicky Brocklebank Sally Johnson Thomas P. Sheerin Stephen D. Marks Rodney D. Gilbert Kay Tyerman Meredith Kinoshita Atif Awan Amrit Kaur Nicholas Webb Shivaram Hegde Eric Finlay Maggie Fitzpatrick Patrick R. Walsh Edwin K.S. Wong Caroline Booth Larissa Kerecuk Alan D. Salama Mike Almond Carol Inward Timothy H. Goodship Neil S. Sheerin Kevin J. Marchbank David Kavanagh

Factor H autoantibodies can impair complement regulation, resulting in atypical hemolytic uremic syndrome, predominantly in childhood. There are no trials investigating treatment, and clinical practice is only informed by retrospective cohort analysis. Here we examined 175 children presenting with atypical hemolytic uremic syndrome in the United Kingdom and Ireland for factor H autoantibodies t...

2017
Anthony M. Smith Kalule J. Bosco Mark P. Nicol Jackie Kleynhans Mignon McCulloch Sanelisiwe T. Duze Arshad Ismail Mushal Allam Nomsa P. Tau Karen H. Keddy

Shiga toxin-producing Escherichia coli (STEC) strains are primarily foodborne pathogens that may cause diarrheal outbreaks and are associated with severe complications, specifically hemolytic-uremic syndrome (HUS). We report here genome sequence data for STEC O26:H11, which is associated with a cluster of cases of HUS, a rarely described syndrome in South Africa.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید